AvantGen Awarded Contract from NIH to Expedite the Commercialization of Its AccuRate COVID-19 SelfCheck OTC Test
AvantGen, a San Diego-based biotechnology company with a superior yeast display technology for facile antibody discovery and optimization, has entered the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to expedite the commercialization of its... - March 09, 2022
Press Releases 1 - 1 of 1